US should lift curbs on export of covid-19 vaccine raw material: Poonawala
Poonawalla had earlier said that SII has been facing problems in sending out required number of batches of vaccines due to the bureaucratic and government-related hurdles
Mumbai: Serum Institute of India (SII) CEO Adar Poonawalla on Friday said the US needs to lift its embargo on raw material exports to help ramp up vaccine production.
SII is currently manufacturing anti-coronavirus vaccine Covishield, developed by Astrazeneca and Oxford University. The vaccine is not only being used in India, but exported to a number of countries.
Poonawalla had earlier admitted that SII has been facing problems in sending out required number of batches of vaccines due to the bureaucratic and government-related hurdles.
Tagging the twitter handle of the President of the United States, Poonawalla said in a tweet, “Respected @POTUS, if we are to truly unite in beating this virus, on behalf of the vaccine industry outside the U.S., I humbly request you to lift the embargo of raw material exports out of the U.S. so that vaccine production can ramp up. Your administration has the details.”